Willow Industries (Willow) unveils their new air filtration system which will benefit cannabis plant health and employee safety.
In a recent press release (1), Willow Industries disclosed their recent product offering, the WillowAir, an air filtration system that is able to catch and remove contaminants that are airborne. This contributes to safer work environments for employees and also the air quality that effects cannabis plant health.
Frequently witnessed in the cannabis industry, is the need to have a strong emphasis on cleanliness, as well as employee safety. Willow Industries, WillowAir, helps with these problems by inhaling respiratory irritants, ground cannabis dust, Aspergillus and other airborne pathogens, and other health risks that employees may come across in a cultivation environment (1). This device assists in helping plant health through its’ ability to lower microbial exposure and cross-contamination risk.
“As a company committed to innovation and excellence, we are proud to be a part of the movement towards employee wellness in this industry,” Jill Ellsworth, Founder and CEO, said (1). “Consumer safety and product quality have always been our ethos, and WillowAir further supports our mission.”
The WillowAir is a MERV 13 rated system that has the capacity to inhale contaminants as small as 0.3 microns (1). Willow Industries device can filter a space of 10,000 cubic feet. The air filtration system is able to be utilized in office spaces, packaging areas, grow rooms, and post-harvest production. It also does not need to rely on other adaptive components such as, Ozone and ultraviolet (UV). To purchase the WillowAir system, Willow Industries launched an online store for easier access to the air filtration system and other product offerings to help cannabis cultivators manage a clean environment. This has been called “Clean Cannabis Essentials” (1).
To learn more about the WillowAir (2), please visit: https://willowindustries.com/willowair/.
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.